(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Sana Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2027 to be $5,138,963,075, with the lowest SANA revenue forecast at $5,138,963,075, and the highest SANA revenue forecast at $5,138,963,075. On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $26,006,267,685, with the lowest SANA revenue forecast at $26,006,267,685, and the highest SANA revenue forecast at $26,006,267,685.
In 2029, SANA is forecast to generate $66,939,999,541 in revenue, with the lowest revenue forecast at $66,939,999,541 and the highest revenue forecast at $66,939,999,541.